Targeting Methyltransferase-Independent Functions of Dot1l in MLL-Rearranged Leukemia

Momentum Fellow (2018-2019)

Dr. Perner is investigating the mechanisms of resistance to targeted therapy in MLL-rearranged leukemia to identify strategies to improve treatments.

BACK TO OUR PORTFOLIO